论文信息 - Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer - 字舞流文

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Jeremy R. Duvall | S. Collins | Phonphimon Wongthida | M. Damelin | Liuliang Qin | Kalli C Catcott | T. Lowinger | A. Dirksen | C. Chin | Fu Li | Jason Wang | D. Toader | P. Conlon | S. Fessler | Ling Xu | Elena Ter-Ovanesyan | Bingfan Du | R. Mosher | M. Yin | M. Kozytska | P. Shaw | Kamela Bellovoda | C. Routhier | S. Higgins | Elizabeth Ditty | Aleksandr V Yurkovetskiy | Cheri A Stevenson | Stephen P Bradley | David H Lee | Reddy Bollu | Chelsey Faircloth